The Silent Threat: Chronic Heart Failure (CHF)

Chronic Heart Failure (CHF) is a debilitating condition that affects millions worldwide. Early detection and management are crucial for improving patient outcomes and reducing hospitalizations. The Chronic Heart Failure Early Warning Score System (CHESS) is a valuable tool for assessing the risk of adverse events in CHF patients.

The High Cost of Heart Failure: A Silent Epidemic

CHF imposes a significant burden on patients, caregivers, and healthcare systems. The condition can lead to reduced quality of life, increased hospitalizations, and high healthcare costs. Effective management of CHF requires early identification of patients at high risk for adverse events.

Kribado: Your Solution for Heart Failure Management

Kribado is an innovative risk stratification and behavior setting device designed to address the challenges of CHF management. By accurately assessing patients’ risk for adverse events using the CHESS score, Kribado empowers healthcare providers to implement preventive measures and optimize treatment plans.

This cutting-edge solution offers a non-invasive screening process that delivers instant insights, enabling efficient patient triage and resource allocation. Kribado’s user-friendly interface and streamlined data collection ensure accurate and reliable results.

Indigital Technologies: Your Partner in Heart Health

Indigital Technologies is a leading pharmaceutical business growth expert with a proven track record of success. Our 9-year journey has involved collaborating with 653 pharmaceutical brands across 8 countries, generating over 9700 crores in revenue.

We are committed to developing innovative solutions that address critical healthcare challenges. With over 200 COAs and expertise across 12 therapeutic areas, Kribado represents our dedication to improving patient lives.